Category Archives: Jim’s Corner

Simpson Bowles Keynote to Address Debt, Taxes, Government Services and Politics

Jim Greenwood

I was recently asked what the single biggest threat to the biotechnology industry is today.  My answer was immediate – the biggest threat to biotech innovation is the unsustainable mismatch of spending and revenue in the U.S. federal budget. The enormous national debt and the huge annual budget deficits that feed it endanger America’s entire economic future – but the nation’s dire fiscal situation is particularly threatening to our industry. Part of the reason for Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , ,

The Presidential Inaugural: BIO Stands Ready to work with President Obama

Jim Greenwood

Today we congratulate President Obama on his swearing-in as President of the United States. BIO looks forward to continuing to work with the president and his administration over the next four years to craft policies that will help create jobs, propel continued innovation, and increase our nation’s competitiveness in the global marketplace. The United States remains the world leader in biotechnology. Our nation’s biotechnology industry is comprised of scientists, entrepreneurs and large and small companies Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

How the Biotechnology Industry Can Combat Doping in Sports

Track

Biotechnology companies work every day to solve some of our biggest global challenges – fighting disease, hunger and pollution. Yet, we in the biotech industry are strongly aware that our products can also be misused in the wrong hands. The same medicines that can be used to help children with devastating genetic deficiencies and growth disorders, or to help a chemotherapy patient combat cancer, can also be abused by healthy athletes to gain an unfair Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , , , ,

New Drug Disposal Law Doesn’t Make Sense

rxpills-btn

Product stewardship is a broad term applied across many industries, encompassing environmental, health, and safety concerns. Companies in each sector of the biotech industry (healthcare, agricultural, and industrial and environmental) have championed stewardship programs for many years – not just because it makes good business sense, but because they believe it is the right thing to do. Within the healthcare space, the impact of pharmaceuticals in the environment has become an issue of emerging debate. Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: ,

Research: Working Together Toward Cures

Jim Greenwood

Modern biomedical innovation and the discovery of new cures and therapies for devastating diseases require robust collaboration and coordination among industry, research institutions and physicians. By bringing together the brightest minds in medical research, our nation’s research enterprise has successfully brought hundreds of new drugs, biologics, and vaccines to market in recent years and developed a wealth of clinical prescribing information. Ongoing research is advancing the fight against some of humanity’s worst scourges, such as Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,